nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—MTHFR—cervical cancer	0.66	1	CbGaD
Menadione—F9—Intrinsic Pathway—SERPIND1—cervical cancer	0.0101	0.0519	CbGpPWpGaD
Menadione—F9—Intrinsic Pathway—GP5—cervical cancer	0.00882	0.0454	CbGpPWpGaD
Menadione—PROC—Common Pathway—SERPIND1—cervical cancer	0.00871	0.0448	CbGpPWpGaD
Menadione—PROS1—Common Pathway—SERPIND1—cervical cancer	0.00771	0.0397	CbGpPWpGaD
Menadione—PROC—Intrinsic Pathway—SERPIND1—cervical cancer	0.00742	0.0382	CbGpPWpGaD
Menadione—F9—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.0068	0.035	CbGpPWpGaD
Menadione—PROC—Intrinsic Pathway—GP5—cervical cancer	0.00649	0.0334	CbGpPWpGaD
Menadione—F7—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.00597	0.0307	CbGpPWpGaD
Menadione—F9—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.00595	0.0306	CbGpPWpGaD
Menadione—F10—Common Pathway—SERPIND1—cervical cancer	0.00587	0.0302	CbGpPWpGaD
Menadione—PROZ—renal system—cervical cancer	0.00576	0.0394	CbGeAlD
Menadione—F7—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.00522	0.0269	CbGpPWpGaD
Menadione—PROC—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.005	0.0258	CbGpPWpGaD
Menadione—F10—Intrinsic Pathway—SERPIND1—cervical cancer	0.005	0.0257	CbGpPWpGaD
Menadione—F9—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.00458	0.0236	CbGpPWpGaD
Menadione—PROS1—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.00443	0.0228	CbGpPWpGaD
Menadione—PROC—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.00437	0.0225	CbGpPWpGaD
Menadione—F10—Intrinsic Pathway—GP5—cervical cancer	0.00437	0.0225	CbGpPWpGaD
Menadione—F7—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.00402	0.0207	CbGpPWpGaD
Menadione—PROS1—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.00387	0.0199	CbGpPWpGaD
Menadione—BGLAP—Interleukin-11 Signaling Pathway—PIAS3—cervical cancer	0.00378	0.0195	CbGpPWpGaD
Menadione—F2—Common Pathway—SERPIND1—cervical cancer	0.00362	0.0186	CbGpPWpGaD
Menadione—F10—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.00337	0.0174	CbGpPWpGaD
Menadione—PROC—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.00337	0.0173	CbGpPWpGaD
Menadione—F9—epithelium—cervical cancer	0.00335	0.023	CbGeAlD
Menadione—F7—renal system—cervical cancer	0.00325	0.0223	CbGeAlD
Menadione—VKORC1L1—decidua—cervical cancer	0.00312	0.0214	CbGeAlD
Menadione—F9—renal system—cervical cancer	0.00311	0.0213	CbGeAlD
Menadione—F2—Intrinsic Pathway—SERPIND1—cervical cancer	0.00308	0.0159	CbGpPWpGaD
Menadione—VKORC1L1—renal system—cervical cancer	0.00307	0.021	CbGeAlD
Menadione—BGLAP—Notch-mediated HES/HEY network—YY1—cervical cancer	0.003	0.0155	CbGpPWpGaD
Menadione—PROS1—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.00298	0.0154	CbGpPWpGaD
Menadione—F10—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.00295	0.0152	CbGpPWpGaD
Menadione—F2—Intrinsic Pathway—GP5—cervical cancer	0.00269	0.0139	CbGpPWpGaD
Menadione—F7—female reproductive system—cervical cancer	0.00261	0.0179	CbGeAlD
Menadione—F9—female reproductive system—cervical cancer	0.00249	0.0171	CbGeAlD
Menadione—VKORC1L1—female reproductive system—cervical cancer	0.00246	0.0168	CbGeAlD
Menadione—F7—female gonad—cervical cancer	0.00237	0.0162	CbGeAlD
Menadione—F10—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.00227	0.0117	CbGpPWpGaD
Menadione—F9—female gonad—cervical cancer	0.00227	0.0155	CbGeAlD
Menadione—F9—vagina—cervical cancer	0.00225	0.0154	CbGeAlD
Menadione—VKORC1L1—female gonad—cervical cancer	0.00223	0.0153	CbGeAlD
Menadione—PROC—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.00223	0.0115	CbGpPWpGaD
Menadione—VKORC1L1—vagina—cervical cancer	0.00222	0.0152	CbGeAlD
Menadione—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.00208	0.0107	CbGpPWpGaD
Menadione—GGCX—uterine cervix—cervical cancer	0.00198	0.0136	CbGeAlD
Menadione—PROS1—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.00197	0.0101	CbGpPWpGaD
Menadione—BGLAP—renal system—cervical cancer	0.0019	0.013	CbGeAlD
Menadione—GGCX—decidua—cervical cancer	0.00189	0.0129	CbGeAlD
Menadione—PROS1—uterine cervix—cervical cancer	0.00188	0.0129	CbGeAlD
Menadione—GGCX—renal system—cervical cancer	0.00185	0.0127	CbGeAlD
Menadione—F2—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.00182	0.00935	CbGpPWpGaD
Menadione—PROS1—decidua—cervical cancer	0.00179	0.0123	CbGeAlD
Menadione—GGCX—endometrium—cervical cancer	0.00179	0.0123	CbGeAlD
Menadione—F2—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.00178	0.00914	CbGpPWpGaD
Menadione—F10—uterine cervix—cervical cancer	0.00177	0.0121	CbGeAlD
Menadione—PROS1—renal system—cervical cancer	0.00176	0.0121	CbGeAlD
Menadione—GGCX—mammalian vulva—cervical cancer	0.00173	0.0119	CbGeAlD
Menadione—PROS1—endometrium—cervical cancer	0.0017	0.0117	CbGeAlD
Menadione—F10—decidua—cervical cancer	0.00169	0.0116	CbGeAlD
Menadione—GGCX—uterus—cervical cancer	0.00165	0.0113	CbGeAlD
Menadione—PROS1—mammalian vulva—cervical cancer	0.00165	0.0113	CbGeAlD
Menadione—F10—endometrium—cervical cancer	0.0016	0.011	CbGeAlD
Menadione—VKORC1—renal system—cervical cancer	0.00159	0.0109	CbGeAlD
Menadione—PROS1—uterus—cervical cancer	0.00157	0.0107	CbGeAlD
Menadione—F10—mammalian vulva—cervical cancer	0.00155	0.0106	CbGeAlD
Menadione—BGLAP—female reproductive system—cervical cancer	0.00152	0.0104	CbGeAlD
Menadione—XDH—uterine cervix—cervical cancer	0.00152	0.0104	CbGeAlD
Menadione—GGCX—female reproductive system—cervical cancer	0.00149	0.0102	CbGeAlD
Menadione—VKORC1L1—lymph node—cervical cancer	0.00144	0.00984	CbGeAlD
Menadione—XDH—renal system—cervical cancer	0.00142	0.00974	CbGeAlD
Menadione—PROS1—female reproductive system—cervical cancer	0.00141	0.00966	CbGeAlD
Menadione—F2—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.0014	0.0072	CbGpPWpGaD
Menadione—XDH—endometrium—cervical cancer	0.00138	0.00942	CbGeAlD
Menadione—GGCX—female gonad—cervical cancer	0.00135	0.00926	CbGeAlD
Menadione—GGCX—vagina—cervical cancer	0.00134	0.0092	CbGeAlD
Menadione—XDH—mammalian vulva—cervical cancer	0.00133	0.00911	CbGeAlD
Menadione—F10—female reproductive system—cervical cancer	0.00133	0.00909	CbGeAlD
Menadione—PROS1—female gonad—cervical cancer	0.00128	0.00879	CbGeAlD
Menadione—PROS1—vagina—cervical cancer	0.00128	0.00874	CbGeAlD
Menadione—F2—epithelium—cervical cancer	0.00127	0.00872	CbGeAlD
Menadione—VKORC1—female reproductive system—cervical cancer	0.00127	0.00872	CbGeAlD
Menadione—NQO2—uterine cervix—cervical cancer	0.00126	0.00862	CbGeAlD
Menadione—AOX1—Tryptophan metabolism—UBE3A—cervical cancer	0.00123	0.00635	CbGpPWpGaD
Menadione—F10—female gonad—cervical cancer	0.00121	0.00827	CbGeAlD
Menadione—F10—vagina—cervical cancer	0.0012	0.00822	CbGeAlD
Menadione—NQO2—decidua—cervical cancer	0.0012	0.00821	CbGeAlD
Menadione—F2—renal system—cervical cancer	0.00118	0.00809	CbGeAlD
Menadione—NQO2—renal system—cervical cancer	0.00118	0.00806	CbGeAlD
Menadione—VKORC1—female gonad—cervical cancer	0.00116	0.00793	CbGeAlD
Menadione—XDH—female reproductive system—cervical cancer	0.00114	0.0078	CbGeAlD
Menadione—NQO2—endometrium—cervical cancer	0.00114	0.00779	CbGeAlD
Menadione—NQO2—mammalian vulva—cervical cancer	0.0011	0.00754	CbGeAlD
Menadione—NQO1—epithelium—cervical cancer	0.00106	0.00727	CbGeAlD
Menadione—NQO1—uterine cervix—cervical cancer	0.00105	0.00721	CbGeAlD
Menadione—NQO2—uterus—cervical cancer	0.00105	0.00718	CbGeAlD
Menadione—MAOB—Tryptophan metabolism—UBE3A—cervical cancer	0.00104	0.00537	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00104	0.00534	CbGpPWpGaD
Menadione—XDH—vagina—cervical cancer	0.00103	0.00706	CbGeAlD
Menadione—BGLAP—Notch-mediated HES/HEY network—HES1—cervical cancer	0.00102	0.00526	CbGpPWpGaD
Menadione—NQO1—decidua—cervical cancer	0.001	0.00687	CbGeAlD
Menadione—NQO1—renal system—cervical cancer	0.000985	0.00675	CbGeAlD
Menadione—AOX1—uterine cervix—cervical cancer	0.000966	0.00662	CbGeAlD
Menadione—NQO1—endometrium—cervical cancer	0.000952	0.00652	CbGeAlD
Menadione—MTHFR—female reproductive system—cervical cancer	0.000946	0.00648	CbGeAlD
Menadione—F2—female reproductive system—cervical cancer	0.000946	0.00648	CbGeAlD
Menadione—NQO2—female reproductive system—cervical cancer	0.000942	0.00645	CbGeAlD
Menadione—F2—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.000925	0.00476	CbGpPWpGaD
Menadione—NQO1—mammalian vulva—cervical cancer	0.000921	0.00631	CbGeAlD
Menadione—AOX1—decidua—cervical cancer	0.000921	0.0063	CbGeAlD
Menadione—MTHFR—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000917	0.00472	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000906	0.00466	CbGpPWpGaD
Menadione—AOX1—renal system—cervical cancer	0.000904	0.00619	CbGeAlD
Menadione—F7—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000896	0.00461	CbGpPWpGaD
Menadione—NQO1—uterus—cervical cancer	0.000878	0.00601	CbGeAlD
Menadione—AOX1—endometrium—cervical cancer	0.000874	0.00599	CbGeAlD
Menadione—GGCX—lymph node—cervical cancer	0.000869	0.00595	CbGeAlD
Menadione—MTHFR—female gonad—cervical cancer	0.000861	0.0059	CbGeAlD
Menadione—F2—female gonad—cervical cancer	0.000861	0.0059	CbGeAlD
Menadione—NQO2—female gonad—cervical cancer	0.000858	0.00587	CbGeAlD
Menadione—NQO2—vagina—cervical cancer	0.000852	0.00584	CbGeAlD
Menadione—AOX1—mammalian vulva—cervical cancer	0.000845	0.00579	CbGeAlD
Menadione—PROS1—lymph node—cervical cancer	0.000825	0.00565	CbGeAlD
Menadione—F9—Hemostasis—GP6—cervical cancer	0.000821	0.00423	CbGpPWpGaD
Menadione—F9—Hemostasis—SERPIND1—cervical cancer	0.000821	0.00423	CbGpPWpGaD
Menadione—F2—PAR1-mediated thrombin signaling events—AKAP13—cervical cancer	0.000818	0.00421	CbGpPWpGaD
Menadione—AOX1—uterus—cervical cancer	0.000805	0.00552	CbGeAlD
Menadione—NQO1—female reproductive system—cervical cancer	0.000789	0.0054	CbGeAlD
Menadione—F10—lymph node—cervical cancer	0.000777	0.00532	CbGeAlD
Menadione—BGLAP—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	0.000772	0.00397	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—UBE3A—cervical cancer	0.000768	0.00395	CbGpPWpGaD
Menadione—VKORC1—lymph node—cervical cancer	0.000745	0.0051	CbGeAlD
Menadione—MAOB—uterine cervix—cervical cancer	0.000744	0.0051	CbGeAlD
Menadione—BGLAP—FGF signaling pathway—FGFR3—cervical cancer	0.000736	0.00379	CbGpPWpGaD
Menadione—F7—Folate Metabolism—MTHFR—cervical cancer	0.000729	0.00375	CbGpPWpGaD
Menadione—AOX1—female reproductive system—cervical cancer	0.000724	0.00496	CbGeAlD
Menadione—F7—Hemostasis—GP6—cervical cancer	0.000721	0.00371	CbGpPWpGaD
Menadione—F7—Hemostasis—SERPIND1—cervical cancer	0.000721	0.00371	CbGpPWpGaD
Menadione—NQO1—female gonad—cervical cancer	0.000718	0.00492	CbGeAlD
Menadione—F9—Hemostasis—GP5—cervical cancer	0.000718	0.00369	CbGpPWpGaD
Menadione—NQO1—vagina—cervical cancer	0.000713	0.00489	CbGeAlD
Menadione—MAOB—decidua—cervical cancer	0.000709	0.00486	CbGeAlD
Menadione—MAOB—renal system—cervical cancer	0.000696	0.00477	CbGeAlD
Menadione—CYP2A6—vagina—cervical cancer	0.000684	0.00468	CbGeAlD
Menadione—MAOB—endometrium—cervical cancer	0.000673	0.00461	CbGeAlD
Menadione—AOX1—female gonad—cervical cancer	0.000659	0.00451	CbGeAlD
Menadione—AOX1—vagina—cervical cancer	0.000655	0.00448	CbGeAlD
Menadione—MAOB—mammalian vulva—cervical cancer	0.000651	0.00446	CbGeAlD
Menadione—F7—Hemostasis—GP5—cervical cancer	0.00063	0.00324	CbGpPWpGaD
Menadione—MAOB—uterus—cervical cancer	0.00062	0.00425	CbGeAlD
Menadione—PROC—Hemostasis—SERPIND1—cervical cancer	0.000604	0.00311	CbGpPWpGaD
Menadione—PROC—Hemostasis—GP6—cervical cancer	0.000604	0.00311	CbGpPWpGaD
Menadione—F7—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000579	0.00298	CbGpPWpGaD
Menadione—BGLAP—Notch-mediated HES/HEY network—CD4—cervical cancer	0.000578	0.00297	CbGpPWpGaD
Menadione—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.000576	0.00297	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000567	0.00292	CbGpPWpGaD
Menadione—MAOB—female reproductive system—cervical cancer	0.000558	0.00382	CbGeAlD
Menadione—MTHFR—lymph node—cervical cancer	0.000553	0.00379	CbGeAlD
Menadione—NQO2—lymph node—cervical cancer	0.000551	0.00378	CbGeAlD
Menadione—PROS1—Hemostasis—SERPIND1—cervical cancer	0.000535	0.00275	CbGpPWpGaD
Menadione—PROS1—Hemostasis—GP6—cervical cancer	0.000535	0.00275	CbGpPWpGaD
Menadione—PROC—Hemostasis—GP5—cervical cancer	0.000528	0.00272	CbGpPWpGaD
Menadione—CYP1A1—epithelium—cervical cancer	0.000527	0.00361	CbGeAlD
Menadione—CYP1A1—uterine cervix—cervical cancer	0.000523	0.00358	CbGeAlD
Menadione—MAOB—female gonad—cervical cancer	0.000508	0.00348	CbGeAlD
Menadione—MAOB—vagina—cervical cancer	0.000504	0.00346	CbGeAlD
Menadione—CYP1A2—renal system—cervical cancer	0.000496	0.0034	CbGeAlD
Menadione—CYP1A1—renal system—cervical cancer	0.000489	0.00335	CbGeAlD
Menadione—F2—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000487	0.0025	CbGpPWpGaD
Menadione—BGLAP—Interleukin-11 Signaling Pathway—STAT3—cervical cancer	0.000471	0.00243	CbGpPWpGaD
Menadione—PROS1—Hemostasis—GP5—cervical cancer	0.000467	0.0024	CbGpPWpGaD
Menadione—NQO1—lymph node—cervical cancer	0.000461	0.00316	CbGeAlD
Menadione—CYP1A1—mammalian vulva—cervical cancer	0.000457	0.00313	CbGeAlD
Menadione—BGLAP—Notch-mediated HES/HEY network—STAT3—cervical cancer	0.000447	0.0023	CbGpPWpGaD
Menadione—CYP2E1—renal system—cervical cancer	0.000446	0.00305	CbGeAlD
Menadione—CYP1A1—uterus—cervical cancer	0.000436	0.00298	CbGeAlD
Menadione—F2—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000425	0.00219	CbGpPWpGaD
Menadione—AOX1—lymph node—cervical cancer	0.000423	0.0029	CbGeAlD
Menadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000417	0.00215	CbGpPWpGaD
Menadione—F10—Hemostasis—GP6—cervical cancer	0.000407	0.0021	CbGpPWpGaD
Menadione—F10—Hemostasis—SERPIND1—cervical cancer	0.000407	0.0021	CbGpPWpGaD
Menadione—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.000402	0.00207	CbGpPWpGaD
Menadione—BGLAP—FGF signaling pathway—STAT3—cervical cancer	0.0004	0.00206	CbGpPWpGaD
Menadione—CYP1A1—female reproductive system—cervical cancer	0.000392	0.00268	CbGeAlD
Menadione—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000379	0.00195	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000369	0.0019	CbGpPWpGaD
Menadione—CYP2E1—female reproductive system—cervical cancer	0.000357	0.00245	CbGeAlD
Menadione—CYP1A1—female gonad—cervical cancer	0.000356	0.00244	CbGeAlD
Menadione—F10—Hemostasis—GP5—cervical cancer	0.000356	0.00183	CbGpPWpGaD
Menadione—CYP1A1—vagina—cervical cancer	0.000354	0.00243	CbGeAlD
Menadione—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.000346	0.00178	CbGpPWpGaD
Menadione—MAOB—lymph node—cervical cancer	0.000326	0.00223	CbGeAlD
Menadione—F2—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000312	0.0016	CbGpPWpGaD
Menadione—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.000289	0.00148	CbGpPWpGaD
Menadione—F7—Folate Metabolism—TP53—cervical cancer	0.000277	0.00142	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000266	0.00137	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000258	0.00133	CbGpPWpGaD
Menadione—F2—Folate Metabolism—MTHFR—cervical cancer	0.000254	0.0013	CbGpPWpGaD
Menadione—F2—Hemostasis—SERPIND1—cervical cancer	0.000251	0.00129	CbGpPWpGaD
Menadione—F2—Hemostasis—GP6—cervical cancer	0.000251	0.00129	CbGpPWpGaD
Menadione—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000251	0.00129	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000244	0.00126	CbGpPWpGaD
Menadione—MTHFR—Fluoropyrimidine Activity—TP53—cervical cancer	0.000244	0.00125	CbGpPWpGaD
Menadione—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000241	0.00124	CbGpPWpGaD
Menadione—CYP1A1—lymph node—cervical cancer	0.000229	0.00157	CbGeAlD
Menadione—NQO1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000225	0.00116	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000225	0.00116	CbGpPWpGaD
Menadione—F2—Hemostasis—GP5—cervical cancer	0.000219	0.00113	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—TP53—cervical cancer	0.000219	0.00113	CbGpPWpGaD
Menadione—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000201	0.00104	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000201	0.00104	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—TAAR6—cervical cancer	0.000186	0.000956	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000168	0.000863	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—WNT2—cervical cancer	0.000145	0.000746	CbGpPWpGaD
Menadione—PROS1—Immune System—UBE3A—cervical cancer	0.000143	0.000735	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TP53—cervical cancer	0.00014	0.00072	CbGpPWpGaD
Menadione—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000128	0.000661	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000121	0.000623	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TP53—cervical cancer	0.000114	0.000584	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—WNT5A—cervical cancer	0.00011	0.000566	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000107	0.00055	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—TAAR6—cervical cancer	0.000105	0.00054	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	9.79e-05	0.000504	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TP53—cervical cancer	9.63e-05	0.000495	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—TAAR6—cervical cancer	9.54e-05	0.000491	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—CTNNB1—cervical cancer	9.36e-05	0.000482	CbGpPWpGaD
Menadione—MTHFR—Disease—WNT2—cervical cancer	9.12e-05	0.00047	CbGpPWpGaD
Menadione—AOX1—Disease—WNT2—cervical cancer	8.91e-05	0.000459	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—FGFR3—cervical cancer	8.73e-05	0.000449	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DPB1—cervical cancer	8.53e-05	0.000439	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—CASP8—cervical cancer	7.46e-05	0.000384	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—WNT2—cervical cancer	7.44e-05	0.000383	CbGpPWpGaD
Menadione—NQO1—Metabolism—CA9—cervical cancer	7.31e-05	0.000376	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—CTNNB1—cervical cancer	7.31e-05	0.000376	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CA9—cervical cancer	7.22e-05	0.000371	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—AKAP13—cervical cancer	7.2e-05	0.00037	CbGpPWpGaD
Menadione—AOX1—Metabolism—CA9—cervical cancer	7.05e-05	0.000363	CbGpPWpGaD
Menadione—MTHFR—Disease—WNT5A—cervical cancer	6.92e-05	0.000356	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—CTNNB1—cervical cancer	6.9e-05	0.000355	CbGpPWpGaD
Menadione—AOX1—Disease—WNT5A—cervical cancer	6.75e-05	0.000348	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	6.66e-05	0.000343	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	6.66e-05	0.000343	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DQB1—cervical cancer	6.66e-05	0.000343	CbGpPWpGaD
Menadione—XDH—Metabolism—CA9—cervical cancer	6.55e-05	0.000337	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AKAP13—cervical cancer	6.54e-05	0.000336	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—CTNNB1—cervical cancer	6.41e-05	0.00033	CbGpPWpGaD
Menadione—PROS1—Immune System—CD8A—cervical cancer	6.22e-05	0.00032	CbGpPWpGaD
Menadione—F9—Hemostasis—TP53—cervical cancer	6.18e-05	0.000318	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—MTOR—cervical cancer	6.14e-05	0.000316	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—CD4—cervical cancer	6.13e-05	0.000315	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	5.98e-05	0.000308	CbGpPWpGaD
Menadione—MAOB—Metabolism—CA9—cervical cancer	5.96e-05	0.000307	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—CTNNB1—cervical cancer	5.72e-05	0.000294	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—WNT5A—cervical cancer	5.64e-05	0.00029	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TAAR6—cervical cancer	5.63e-05	0.00029	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—CTNNB1—cervical cancer	5.44e-05	0.00028	CbGpPWpGaD
Menadione—F7—Hemostasis—TP53—cervical cancer	5.42e-05	0.000279	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—CTNNB1—cervical cancer	5.37e-05	0.000277	CbGpPWpGaD
Menadione—PROS1—Immune System—FGFR3—cervical cancer	5.08e-05	0.000262	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—CTNNB1—cervical cancer	4.76e-05	0.000245	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—cervical cancer	4.54e-05	0.000234	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	4.46e-05	0.000229	CbGpPWpGaD
Menadione—F2—Signaling Pathways—WNT2—cervical cancer	4.4e-05	0.000226	CbGpPWpGaD
Menadione—PROS1—Immune System—CASP8—cervical cancer	4.35e-05	0.000224	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—EGFR—cervical cancer	4.31e-05	0.000222	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	4.25e-05	0.000219	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	4.25e-05	0.000219	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—cervical cancer	4.02e-05	0.000207	CbGpPWpGaD
Menadione—MTHFR—Disease—HES1—cervical cancer	3.98e-05	0.000205	CbGpPWpGaD
Menadione—AOX1—Disease—HES1—cervical cancer	3.89e-05	0.0002	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKAP13—cervical cancer	3.86e-05	0.000199	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—CTNNB1—cervical cancer	3.62e-05	0.000186	CbGpPWpGaD
Menadione—PROS1—Immune System—MTOR—cervical cancer	3.58e-05	0.000184	CbGpPWpGaD
Menadione—PROS1—Immune System—CD4—cervical cancer	3.57e-05	0.000184	CbGpPWpGaD
Menadione—MTHFR—Disease—TERT—cervical cancer	3.49e-05	0.000179	CbGpPWpGaD
Menadione—AOX1—Disease—MTHFR—cervical cancer	3.42e-05	0.000176	CbGpPWpGaD
Menadione—AOX1—Disease—TERT—cervical cancer	3.41e-05	0.000175	CbGpPWpGaD
Menadione—F2—Signaling Pathways—WNT5A—cervical cancer	3.33e-05	0.000171	CbGpPWpGaD
Menadione—MTHFR—Disease—FGFR3—cervical cancer	3.2e-05	0.000165	CbGpPWpGaD
Menadione—PROS1—Immune System—CTNNB1—cervical cancer	3.17e-05	0.000163	CbGpPWpGaD
Menadione—AOX1—Disease—FGFR3—cervical cancer	3.13e-05	0.000161	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—cervical cancer	3.06e-05	0.000158	CbGpPWpGaD
Menadione—MTHFR—Disease—NOTCH1—cervical cancer	3e-05	0.000155	CbGpPWpGaD
Menadione—NQO1—Metabolism—MTHFR—cervical cancer	2.96e-05	0.000153	CbGpPWpGaD
Menadione—AOX1—Disease—NOTCH1—cervical cancer	2.93e-05	0.000151	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CA9—cervical cancer	2.9e-05	0.000149	CbGpPWpGaD
Menadione—AOX1—Metabolism—MTHFR—cervical cancer	2.86e-05	0.000147	CbGpPWpGaD
Menadione—PROS1—Immune System—STAT3—cervical cancer	2.76e-05	0.000142	CbGpPWpGaD
Menadione—XDH—Metabolism—MTHFR—cervical cancer	2.66e-05	0.000137	CbGpPWpGaD
Menadione—PROS1—Immune System—EGFR—cervical cancer	2.51e-05	0.000129	CbGpPWpGaD
Menadione—MAOB—Metabolism—MTHFR—cervical cancer	2.42e-05	0.000124	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NOTCH2—cervical cancer	2.34e-05	0.00012	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CA9—cervical cancer	2.29e-05	0.000118	CbGpPWpGaD
Menadione—MTHFR—Disease—MTOR—cervical cancer	2.25e-05	0.000116	CbGpPWpGaD
Menadione—MTHFR—Disease—CD4—cervical cancer	2.25e-05	0.000116	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CTNNB1—cervical cancer	2.23e-05	0.000115	CbGpPWpGaD
Menadione—AOX1—Disease—MTOR—cervical cancer	2.2e-05	0.000113	CbGpPWpGaD
Menadione—AOX1—Disease—CD4—cervical cancer	2.19e-05	0.000113	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CA9—cervical cancer	2.16e-05	0.000111	CbGpPWpGaD
Menadione—MTHFR—Disease—CTNNB1—cervical cancer	2e-05	0.000103	CbGpPWpGaD
Menadione—AOX1—Disease—CTNNB1—cervical cancer	1.95e-05	0.0001	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HES1—cervical cancer	1.92e-05	9.87e-05	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—cervical cancer	1.89e-05	9.71e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—STAT3—cervical cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Menadione—AOX1—Disease—STAT3—cervical cancer	1.7e-05	8.74e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TERT—cervical cancer	1.68e-05	8.65e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—EGFR—cervical cancer	1.58e-05	8.14e-05	CbGpPWpGaD
Menadione—AOX1—Disease—EGFR—cervical cancer	1.54e-05	7.95e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FGFR3—cervical cancer	1.54e-05	7.94e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NOTCH1—cervical cancer	1.45e-05	7.45e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CA9—cervical cancer	1.38e-05	7.09e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—EGFR—cervical cancer	1.29e-05	6.64e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—MTHFR—cervical cancer	1.18e-05	6.06e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MTOR—cervical cancer	1.08e-05	5.58e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CASP3—cervical cancer	9.98e-06	5.13e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CTNNB1—cervical cancer	9.62e-06	4.95e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—MTHFR—cervical cancer	9.3e-06	4.79e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—MTHFR—cervical cancer	8.77e-06	4.51e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—STAT3—cervical cancer	8.38e-06	4.31e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EGFR—cervical cancer	7.62e-06	3.92e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—cervical cancer	6.4e-06	3.29e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—MTHFR—cervical cancer	5.59e-06	2.88e-05	CbGpPWpGaD
